reSET-O, the first PDT to receive Breakthrough Designation and authorized by FDA in December 2018, is an 84-day Prescription Digital Therapeutic (PDT) for Opioid Use Disorder (OUD) intended to increase retention of patients in outpatient treatment by providing cognitive behavioral therapy (CBT), as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician.

A medically designed health encounter room that is antimicrobial, noise cancelling and incorporates medical sensors. MedBays and sensors include automated health encounters that include provider oversight along with direct to chart interactions. MedBays excel at convenience care, mental health encounters, labs and exams. The MedBay assembles quickly in any chosen location to bring immediately available encounters with providers.

The only Civil Rights capable clinic serving equally in all languages, literacies, races, genders, ages and more. District behavioral health services, portable clinic, primary care and convenience care.

For individuals with substance use disorder (SUD), reSET® is the first FDA-authorized prescription digital therapeutic that’s proven to increase abstinence and treatment retention. Patients download the reSET app to their smartphone for secure, discreet, convenient access to therapy, interactive learning, and support.

A self-serve and augmented encounter space that includes direct to chart patient authoring.

This is the only of its kind on the market today.